Glibenclamide treatment in relapsed transient neonatal diabetes as a result of a KCNJ11 activating mutation (N48D)

Diabetic Medicine

Volumn 26, Issue 5, 2009, Pages 567-569

  Martin Frias M ^a   Colino, E ^a   Perez De Nanclares G ^b   Alonso, M ^a   Ros, P ^a   Barrio, R ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; GLUCAGON; HEMOGLOBIN A1C; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA;

ABSENCE OF SIDE EFFECTS; ANTHROPOMETRY; CASE REPORT; CHILD; DIABETES MELLITUS; DRUG WITHDRAWAL; EVENING DOSAGE; GENE MUTATION; HUMAN; HYPOGLYCEMIA; INFANT; LETTER; LOW DRUG DOSE; MALE; MORNING DOSAGE; NEWBORN DIABETES MELLITUS; NEWBORN DISEASE; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; RECURRENT DISEASE; SCHOOL CHILD;

CHILD; DIABETES MELLITUS; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; MALE; RECURRENCE;

EID: 65549145047     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02704.x     Document Type: Letter

References (6)

1. Rica I, Luzuriaga C, Pérez de Nanclares G, Estalella I, Aragonés A, Barrio R et al. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities. Diabet Med 2007 24 : 707 713. (Pubitemid 47012125)
2. Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, Robinson D et al. Mutation in ATP-sensitive K+ channel genes cause transient and permanent diabetes in childhood or adulthood. Diabetes 2007 56 : 1930 1937.
3. Colombo C, Delvecchio M, Zecchino C, Faienza MF, Cavallo L, Barbetti F. Transient neonatal diabetes mellitus is associated with a recurrent (R2001H) KCNJ11 (KIR6.2) mutation. Diabetologia 2005 48 : 2439 2441. (Pubitemid 41618938)
4. Landau Z, Wainstein J, Hanukoglu A, Tuval M, Lavie J, Glaser B. Sulfonylurea-responsive diabetes in childhood. J Pediatr 2007 150 : 553 555. (Pubitemid 46602349)
5. Girard CA, Shimomura K, Proks P, Absalom N, Castaño L, Perez de Nanclares G et al. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes. Pflugers Arch 2006 453 : 323 332.
6. Hattersley AT, Aschcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights and new therapy. Diabetes 2005 54 : 2503 2513. (Pubitemid 41233571)